Literature DB >> 4138440

Properties of intracytoplasmic A particles isolated from oncornavirus-producing human cells.

A G Bukrinskaya, G G Miller, E N Lebedeva, L V Agaphonova, N N Masurenko, K V Ilyin.   

Abstract

A particles with the diameter of 70 to 80 nm were isolated from the cytoplasm of HEp-2, HeLa, and AO cells producing oncornavirus of Mason-Pfizer-like type. Most of the A particles banded at 1.23 to 1.24 g/ml, whereas 3 to 10% banded at 1.29 g/ml in equilibrium sucrose gradients. They banded at 1.30 g/ml in CsCl gradients suggesting that they contained 8% RNA. Individual A particles sedimented at 200 to 250S in velocity sucrose gradients, but their significant part was found aggregated and sedimented at more than 300S. They were resistant to RNase digestion. A particles possessed polymerase activity which was preferentially activated by Mn(2+) rather than by Mg(2+), the RNA template being 60S RNA. Cross-hybridization with two DNA products and immunoassay showed that A particles and Mason-Pfizer-like oncornavirus produced by the same cells contained neither homological RNA sequences nor common antigens, suggesting that A particles are not intracellular precursors of Mason-Pfizer-like oncornavirus but represent an independent oncornavirus. Hybridization of A particle RNA with excess of cellular DNA revealed about 20 proviral copies per HEp-2 cell genome and no proviral copies in human embryo and placenta cell genomes.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4138440      PMCID: PMC355600     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Isolation and partial characterization of intracytoplasmic A particles.

Authors:  G H Smith; N A Wivel
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

2.  Properties of the intracytoplasmic A particles purified from mouse tumors.

Authors:  H Tanaka; A Tamura; D Tsujimura
Journal:  Virology       Date:  1972-07       Impact factor: 3.616

3.  Characteristics of the structural components of the mouse mammary tumor virus. I. Morphological and biochemical studies.

Authors:  N H Sarkar; R C Nowinski; D H Moore
Journal:  Virology       Date:  1971-10       Impact factor: 3.616

4.  Analysis of high-molecular-weight ribonucleic acid associated with intracisternal A particles.

Authors:  S S Yang; N A Wivel
Journal:  J Virol       Date:  1973-02       Impact factor: 5.103

5.  The second Sir Hans Krebs Lecture. Informosomes.

Authors:  A S Spirin
Journal:  Eur J Biochem       Date:  1969-08

6.  [Isolation and purification of viral particles of type A present in the cytoplasm of mediastinal lymphoma induced by ethyl-urethane in Swiss mice].

Authors:  J P Kerckaert; J Montreuil; M C Doyennette; F Puvion; M N Vlaeminck; A Verbert; A Demaille; J Driessens
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1970-08-10

7.  Intracytoplasmic A particles: mouse mammary tumor virus nucleoprotein cores?

Authors:  G H Smith; N A Wivel
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

8.  Electron microscopic study of the mammary tumor agent in plasma cell tumors.

Authors:  A J Dalton; M Potter
Journal:  J Natl Cancer Inst       Date:  1968-06       Impact factor: 13.506

9.  Ultrastructural comparison of a virus from a Rhesus-monkey mammary carcinoma with four oncogenic RNA viruses.

Authors:  B Kramarsky; N H Sarkar; D H Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  Leukemia viruses associated with mouse myeloma cells.

Authors:  J Watson; P Ralph; S Sarkar; M Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

View more
  1 in total

1.  Relationships between intracisternal type A and extracellular oncornavirus-like particles produced in murine MOPC-460 myeloma cells.

Authors:  D L Robertson; P Yau; D C Dobbertin; T K Sweeney; S S Thach; T Brendler; R E Thach
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.